Cavalier Michael sold (to issuer) $3.8M of CNK (indirect holdings)

Cavalier Michael (EVP-General Counsel) sold (to issuer) 107,296 indirectly-held shares of Cinemark Holdings, Inc. (CNK) at $35.02 ($3.76M total) on 2026-09-01 under a Rule 10b5-1 trading plan.

Original reporting
SEC EDGAR · Cavalier Michael
Published Sep 3, 2026, 4:00 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Sep 4, 2026, 7:10 AM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefInsider activity
Primary signal
$CNK
Neutral
medium confidence
Mentioned
$CNK
Relevance
5/10
AlphAI data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$CNKNeutralLow
01

Why it matters

The sale reduces insider ownership but does not alter control; market may view it as neutral.

02

Market read

Primary insider sale filing; modest relevance for short‑term traders.

03

What to watch

Potential upcoming corporate actions or financing needs not disclosed.

Relevance 5/10Novelty 6/10Timing: same‑day filing (2026‑09‑03)

Background

Form 4 filings disclose insider transactions; investors monitor them for sentiment cues.

Company-level read

Ticker impact

$CNKNeutralMedium confidence
Context

EVP-General Counsel sold 107,296 shares for $3.76M via 10b5-1 plan, reducing holdings to 223,385 shares.

Expected impact

Potential slight downward pressure in short term; limited long‑term effect.

Evidence & confidence

The transaction is a primary Form 4 filing, sizable for an insider but not material enough to drive a large move.

Market effects

Minimal impact on entertainment/theater sector; insider sales are routine.

No significant regional effect.

Limited relevance beyond Cinemark investors.

Counterpoint

The sale could be a routine liquidity event rather than a negative signal.

Key entities

  • Cavalier Michael

    EVP‑General Counsel of Cinemark Holdings, reporting the sale.

  • Cinemark Holdings, Inc.

    US‑listed theater operator (ticker CNK).

Full insider trading history

This story covers one filing. See everything behind it: every insider buy and sell on record, 10b5-1 plans, late filings, and which officers and directors are trading.

Related articles

$CNKHigh

Morgan Stanley upgrades Cinemark stock rating on box office outlook

Morgan Stanley upgraded Cinemark (CNK) to Overweight with a $50 price target, citing optimism about 2027 box office growth and the company's strong market position. Cinemark's stock has risen 75.3% year-to-date, trading near its 52-week high. The company reported record Q3 earnings of $1.04 per share on $1.06 billion revenue, exceeding expectations. Other analysts have also raised their price targets following the strong performance.

$CNKHighAI 8/10

StoneX raises Cinemark stock price target on strong quarter

StoneX raised its price target on Cinemark (NYSE:CNK) to $45 from $40, citing strong Q3 results with revenue and adjusted EBITDA exceeding estimates. The firm expects continued growth in 2027, supported by a strong film slate and premium expansion. Cinemark's stock has surged 42% in six months. The company reported record Q3 earnings of $1.04 per share, beating estimates, with revenue reaching $1.06 billion.

$CNKMedAI 8/10

Cinemark stock holds at Neutral as B.Riley keeps $42 target

B.Riley maintained a Neutral rating and $42 price target for Cinemark (CNK) after its Q3 earnings beat estimates. Revenue was $1.059B, EBITDA $268M, driven by Latin America sales. Management is optimistic about future box office growth. Shares are up 65% YTD, trading near a 52-week high. Wells Fargo raised its target to $42, citing international success.

$CNKMed

Cinemark Holdings Inc (CNK) (Q3 2026) Earnings Call Highlights: Record Q3 Revenue

Cinemark Holdings (CNK) reported record Q3 2026 revenue, but faced market share compression due to film mix and capacity constraints. The company expects similar challenges in Q4. Cinemark declined to book Netflix's 'Cliff Booth' on IMAX, citing concerns about the release model. Inflationary pressures and capacity constraints are impacting operations. The company has excess cash and may increase buybacks or dividends. CapEx could rise to invest in new builds and theater enhancements.